Funded Tech Companies
Galecto
Galecto, based in Copenhagen, received equity investments from HBM Healthcare Investments, Bristol-Myers Squibb and OrbiMed.
Company Overview
Company Name
Galecto
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Ole Maaloes Vej 3
Copenhagen, DK-2200
Denmark
Copenhagen, DK-2200
Denmark
Phone
Website
Email Address
Company Background Information
Overview
Galecto (Nasdaq: GLTO) is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer. Galecto was founded by leading fibrosis-focused scientists and biotech executives and is built on more than 10 years of research into galectin.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/28/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hans Schambye
Chief Financial Officer
Jonathan Freve
Chief Marketing Officer
Bertil Lindmark
Chief Operating Officer
Anders Pedersen
Company Investors
- HBM Healthcare Investments
- Bristol-Myers Squibb
- OrbiMed
- Soleus Capital (Guy Levy)
- Canica
- Novo Ventures
- Sunstone Capital
- Hadean Ventures
- Sphera Global Health Care Fund
- Eir Ventures (Stephan Christgau)
- Maverick Ventures Israel
- Seventure Partners
- Ysios Capital
- Cormorant Asset Management
- Asymmetry Capital Management
- Janus Henderson Investors
Browse more funded tech companies:
Gale Technologies | Galen Robotics
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs